IRANIAN JOURNAL OF KIDNEY DISEASES, cilt.9, sa.3, ss.221-229, 2015 (SCI İndekslerine Giren Dergi)
Introduction. Methotrexate, an antagonist of folic acid used in the treatment of many cancers and inflammatory diseases, is associated with side effects that limit its usage. Infliximab has been reported to have a protective effect against nephrotoxicity induced by some drugs and ischemic reperfusion. We aimed to investigate whether infliximab has a protective effect against methotrexate-induced nephrotoxicity.